Industry Insights

Empowering the Next Generation: How ASPET ISC Aims to Expose Trainees to Life Sciences Industry

Authors:
Vrushank Bhatt, Senior Scientist, Bristol-Myers Squibb Company
Hiranmayee Kandala, Principal Scientist, Amgen
Marcus Delatte, VP Regulatory Strategy, Allucent

The life sciences industry, comprised of small biotech startups, mid-sized firms, large pharmaceuticals and contract research organizations (CROs), is experiencing rapid transformation driven by scientific innovations, new business models, and a growing emphasis on translational research. Advances in genomics, data science, and personalized medicine have accelerated drug discovery and development which, with increased venture capital investments and small company buyouts, have created a fast-paced, innovation-enabling environment. This diversification has opened doors to numerous career opportunities and roles, ranging from research and development to regulatory affairs, business development, and data science. In addition to a strong foundation in life sciences, industry employers increasingly value soft skills such as project management, cross-functional collaboration, effective communication, and quantitative/analytical capabilities. Thus, the ability to adapt and learn new technologies is more important than ever in the life sciences industry.

For ASPET members, especially early career scientists and trainees, understanding this rapidly evolving industry is paramount to making informed career choices and ensuring successful professional growth. The ASPET Industry Science Committee (ISC) is well poised to drive the effort to educate ASPET members on the knowledge, skills, and networks needed to thrive in industry settings. To this end, the ISC is developing a suite of workshops and events to help members navigate the transition from academia to industry, including topics such as:

• Panel Discussions on Industry Trends: This will feature representatives from pharma, biotech, CROs, and venture capital to provide insights into the current landscape and future directions.
• Interactive Seminars on Translational Science: This will explore the journey of breakthrough technologies from bench to bedside, highlighting the critical roles scientists play at each stage of development, and the current trends in regulatory affairs that enable technology and product development.
• Mentorship Mixers: This will give trainees the opportunity to connect with ASPET members who have successfully transitioned to industry roles, gaining valuable advice and building professional relationships.
• Spotlight on CRO and Consultancy Career Pathways: This will bring in professionals from CROs and consultancy companies to share insights into career progression, required skills, and the unique opportunities available in these sectors.
• Skill-Building Sessions: These will focus on essential industry skills such as project management, regulatory affairs, and data analysis, ensuring members are well-prepared for the demands of industry roles.

These events align with the overarching goal of ASPET ISC which is to empower members to navigate the culturally rich and evolving biotech/pharma ecosystem, embrace the diverse roles available to them, and cultivate the skills needed for success. Taken together, these initiatives will provide the knowledge-base and connections to confidently transition from academia to industry.